GSMA
23.9.2020 13:27:09 CEST | Business Wire | Press release
GSMA today announced a rescheduling of its world-class MWC series for 2021. MWC21 Shanghai will now take place from 23 – 25 February 2021, and MWC21 Barcelona will now take place between 28 June – 1 July 2021.
Moving MWC21 Barcelona, initially scheduled for the first week of March 2021, allows the GSMA to contend with external circumstances related to Covid-19.
The GSMA is committed and investing so that MWC21 Barcelona can go ahead safely and offer the unique, unmissable experience that has made it the world’s most important mobile ecosystem convening platform. MWC21 Barcelona will also have virtual elements to complement the overwhelming demand to convene physically.
Mats Granryd, Director General, GSMA said: “With a continuously changing global outlook and following consultation with our board and membership and our top exhibitors, we have taken the careful decision to reschedule MWC21 Shanghai in February, and MWC21 Barcelona in June. The health and safety of our exhibitors, attendees, staff and the people of Barcelona are of paramount importance.”
John Hoffman, CEO GSMA Ltd., said: “We have been overwhelmed by the support of all our partners and clients who remain dedicated to ensuring MWC21 Barcelona is a success. MWC is more than just an event. It’s an experience that brings the whole industry together and provides a platform to unlock the power of connectivity so that people, industry and society thrive.”
The rescheduling respects the global circumstance surrounding Covid-19. It recognises that both events are catalysts in the mobile ecosystem; they are platforms for launching new products and innovations, bringing together decision and deal makers.
The GSMA continues to work closely with the Host City Parties, and the decision to change the date of MWC21 Barcelona follows a period of planning and consultation with all major stakeholders. The date changes also ensure that 2021 reverts to a full annual cycle of MWC events between Shanghai, Barcelona and LA. Both the Host City Parties and the GSMA board support the decision of the GSMA.
Pau Relat, President of Governing board of Fira de Barcelona, said: “We fully support the GSMA’s decision to reschedule the dates for MWC Barcelona and are deeply committed to making the best possible 2021 edition with an extraordinary participation of companies and visitors. The long-standing partnership between the MWC, Fira and the city of Barcelona has been a very successful one for everyone, and I’m sure it will continue to be so in the future.”
Over the balance of 2020, the GSMA remains excited about its virtual series, Thrive, with remaining events in Africa, North America, Asia Pacific, Eurasia and Latin America. For more information, please click here, https://www.gsmathrive.com/ .
- ENDS -
Notes to Editors
Host City Parties include: Barcelona City Council, Generalitat de Catalunya, the Ministry of Industry, Energy and Tourism, Fira de Barcelona, Tourism de Barcelona
About GSMA
The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators with almost 400 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200923005487/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
